Curated GI articles January 20th, 2023: CellMax blood test for CRC | One GI expands in Virginia | Racial disparities in IBD

Curated GI articles January 20th, 2023: CellMax blood test for CRC | One GI expands in Virginia | Racial disparities in IBD

Curated GI articles January 20th, 2023:
CellMax blood test for CRC | One GI expands in Virginia | Racial disparities in IBD
Gastroenterology gains 1,128 physicians over 5 years (Becker’s GI & Endoscopy)
Gastroenterology gained 1,128 active physicians from 2016 to 2021, according to the Association of American Medical College’s “Physician Specialty Data Report.”
One GI® Expands Virginia Footprint Again (PR Newswire)
One GI®, the Home for Independent Gastroenterology, expands Virginia footprint again with Gastroenterology Associates, PC, partnership.
Healthcare Private Equity Down But Not Out, Report Finds (RevCycleIntelligence)
2022 was the second biggest year on record for healthcare private equity despite an uncertain and inflationary market hampering activity by the end of the year.
CellMax Life Announces Positive Results From Prospective Multisite Study of Novel Blood Test to Detect Colorectal Cancer and Pre-Cancer (PR Web)
Data shows 92% sensitivity for colorectal cancer and 55% sensitivity for precancerous advanced adenomas at 91% specificity.
Focus on six key areas for successful physician partnerships (Physicians Practice)
Entering a physicians partnership is not a process that should be rushed through nor taken lightly.
Unclogging the Pipes of Your GI Practice‍ (Telebelly)
Russ Arjal MD (Co-founder and CMO, Telebelly Health) provides insights to improve GI care for patients
America’s physicians are getting older, women are gaining ground, and more data on doctors (Chief Healthcare Executive)
The Association of the American Medical Colleges released a report that offers more insight on the nation’s physician workforce.
At-home bowel cancer tests could help reduce colonoscopies (EurekAlert)
Screening for bowel cancer using at-home faecal immunochemical tests could help to reduce the frequency of colonoscopies for some at above-average risk individuals.
Blood test could help predict which patients with colon cancer need chemotherapy after surgery: Study (ABC News)
A blood test under study may soon be able to help many patients with colon cancer decide whether they need chemotherapy after surgery, or if they can safely skip it.
Digital Health Funding Slows In 2022: Is The Hype Fading Or Is It A Temporary Setback ? (Workweek)
While 2022’s total digital health funding disappointed many, it was anything but unexpected.
Regenstrief Institute research scientists study online colorectal cancer risk calculators (EurekAlert)
Regenstrief Institute and Indiana University School of Medicine research scientists have conducted a study of online colorectal cancer risk calculators.
FIT DNA Screening Results Have Multiple Implications for Follow-up Colonoscopy (GI & Endoscopy News)
Colonoscopies performed after abnormal fecal immunochemical DNA tests are associated with greater detection of lesions, longer withdrawal times and recommendations for shorter intervals.
Top 100 hospitals for gastrointestinal care by state, per Healthgrades (Becker’s GI & Endoscopy)
A list of top hospitals for gastrointestinal care listed by Healthgrades in 2023 by state.
MedPAC asks Congress to increase physician payments (Healio)
The Medicare Payment Advisory Commission, or MedPAC, has recently voted to recommend that Congress increase 2024 Medicare payments for physicians and other health services.
Racial Disparities Seen in Use of IBD Medical Therapy (Pharmacy Practice News)
Black patients with inflammatory bowel disease are less likely to be treated with immunomodulator or biologic therapies than white IBD patients, according to a recent study in a large U.S. cohort.
Advanced colorectal neoplasia prevalence remains low 10 years after negative colonoscopy (Healio)
Screening colonoscopy has been shown to reduce colorectal cancer incidence and mortality by enabling detection and removal of precancerous lesions.
Scant Evidence for Proton Pump Inhibitor Role in Gastric Cancer (Medscape)
The available evidence suggests that proton pump inhibitors (PPIs) do not cause gastric cancer, researchers say.
Helping your patients with NAFLD lose weight (AGA)
Hear key takeaways from AGA’s Clinical Practice Update on NAFLD management.

More Hot headlines in GI

Register: 2023 AGA TeRegister: 2023 AGA Tech Summit (AGA)

SF Interview- Jactel: “Being patient centered is different than being patient driven” (NextServices)

Oshi Health Adds Distinguished Physician-Scientist and Upcoming AGA President Dr. Maria T. Abreu to Medical Advisory Board (PR Web)

Physician Sues AMA for Defamation Over 2022 Election Controversy (Medscape)

‘Clinical paradox’? Bariatric surgery may protect from GI cancers (MDedge)

Novel IgG-Based Elimination Diet Shown to Improve IBS Outcomes (GI & Endoscopy News)

EndoTheia Inc. Announces FDA Breakthrough Device Designation for Technology to Improve Endoscopic Surgery (BusinessWire)

Digesting 2022 and looking forward to 2023 in IBD therapeutics (Healio)

Videos: Interviews with GI Leaders  (Scope Forward Show/NextServices)ch Summit (AGA)

A 2022 Look Back: Increasing GI Expertise with 19 New Providers (MNGI Digestive Health)

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board (Globe Newswire)

Q&A: Gravity’s role in IBS pathogenesis, symptoms: A new hypothesis (Healio)

Dayton Gastroenterology, LLC., Now Incorporates First Artificial Intelligence System for Enhanced Colonoscopy Screenings (PR Newswire)

Longitudinal gut microbial signals are associated with weight loss: insights from a digital therapeutics program (MedRxiv)

Immune checkpoint inhibitor–related gastrointestinal adverse events (MDedge)

The effect of active video games on cognitive functioning in clinical and non-clinical populations: A meta-analysis of randomized controlled trials (Science Direct)

AGA Offers Key Guidance on Managing Subepithelial GI Lesions (Medscape)

At J.P. Morgan healthcare conference, Exact Sciences CEO describes pivotal meeting for Cologuard development (Lab Pulse)

Videos: Interviews with GI Leaders  (Scope Forward Show/NextServices)

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.

Write a Comment